Compare LEGN & MTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LEGN | MTG |
|---|---|---|
| Founded | 2014 | 1957 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.9B | 6.3B |
| IPO Year | 2020 | 2008 |
| Metric | LEGN | MTG |
|---|---|---|
| Price | $17.73 | $29.88 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 12 | 4 |
| Target Price | ★ $61.33 | $28.50 |
| AVG Volume (30 Days) | ★ 1.6M | 1.4M |
| Earning Date | 05-12-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 2.06% |
| EPS Growth | N/A | ★ 8.65 |
| EPS | N/A | ★ 1.62 |
| Revenue | N/A | ★ $1,213,636,000.00 |
| Revenue This Year | $42.68 | $2.50 |
| Revenue Next Year | $30.52 | $1.77 |
| P/E Ratio | ★ N/A | $18.98 |
| Revenue Growth | N/A | ★ 0.49 |
| 52 Week Low | $16.24 | $24.69 |
| 52 Week High | $37.50 | $31.89 |
| Indicator | LEGN | MTG |
|---|---|---|
| Relative Strength Index (RSI) | 35.03 | 53.36 |
| Support Level | $17.81 | $25.57 |
| Resistance Level | $19.36 | $31.61 |
| Average True Range (ATR) | 0.85 | 0.43 |
| MACD | -0.17 | -0.10 |
| Stochastic Oscillator | 8.33 | 35.05 |
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.
MGIC Investment Corp provides private mortgage insurance, other mortgage credit risk management solutions, and ancillary services. The insurance premiums that these customers pay for the protection account for close to the majority of the company's total revenue. Investment income accounts for the remaining revenue. The company sells its insurance products in all states of the United States and in Puerto Rico. Its greatest exposure is in California, Florida, Texas, Pennsylvania, Ohio, Illinois, Virginia, North Carolina, Georgia, and New York.